548773-13-3

548773-13-3结构式
548773-13-3结构式

化源商城直购

中文名 2-氨基-4,6-二甲基嘧啶-5-羧酸
英文名 2-amino-4,6-dimethylpyrimidine-5-carboxylic acid
英文别名 2-Amino-4,6-dimethyl-5-pyrimidinecarboxylic acid
分子式 C7H9N3O2
分子量 167.16500
精确质量 167.06900
PSA 89.83000
LogP 0.30390
储存条件 2-8°C
海关编码 2933599090

~99%

548773-13-3结构式

548773-13-3

文献:Palani, Anandan; Shapiro, Sherry; Clader, John W.; Greenlee, William J.; Vice, Susan; McCombie, Stuart; Cox, Kathleen; Strizki, Julie; Baroudy, Bahige M. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 4 p. 709 - 712

~%

548773-13-3结构式

548773-13-3

文献:McCombie, Stuart W.; Tagat, Jayaram R.; Vice, Susan F.; Lin, Sue-Ing; Steensma, Ruo; Palani, Anandan; Neustadt, Bernard R.; Baroudy, Bahige M.; Strizki, Julie M.; Endres, Michael; Cox, Kathleen; Dan, Niya; Chou, Chuan-Chu Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 3 p. 567 - 571

~%

548773-13-3结构式

548773-13-3

文献:Palani, Anandan; Shapiro, Sherry; Clader, John W.; Greenlee, William J.; Vice, Susan; McCombie, Stuart; Cox, Kathleen; Strizki, Julie; Baroudy, Bahige M. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 4 p. 709 - 712

~%

548773-13-3结构式

548773-13-3

文献:McCombie, Stuart W.; Tagat, Jayaram R.; Vice, Susan F.; Lin, Sue-Ing; Steensma, Ruo; Palani, Anandan; Neustadt, Bernard R.; Baroudy, Bahige M.; Strizki, Julie M.; Endres, Michael; Cox, Kathleen; Dan, Niya; Chou, Chuan-Chu Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 3 p. 567 - 571

~%

548773-13-3结构式

548773-13-3

文献:McCombie, Stuart W.; Tagat, Jayaram R.; Vice, Susan F.; Lin, Sue-Ing; Steensma, Ruo; Palani, Anandan; Neustadt, Bernard R.; Baroudy, Bahige M.; Strizki, Julie M.; Endres, Michael; Cox, Kathleen; Dan, Niya; Chou, Chuan-Chu Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 3 p. 567 - 571
上游产品  4

下游产品  0

海关编码 2933599090
中文概述 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%